GLIA Diagnostics
PrivateLast Round
Seed
Jul 13, 2026
Total Funding Raised
$1.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GLIA Diagnostics operates in Healthcare & Life Sciences and is based in Mosman. Its latest recorded funding round was a Grant round in September 2021.
GLIA Diagnostics is a biotechnology company that develops portable, point-of-care diagnostic platforms for the detection and monitoring of traumatic brain injuries using proprietary microRNA biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Defense Tech
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GLIA Diagnostics Comparables
Compare GLIA Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoDx | 81% | |
| BRAINBox Solutions | 79% | |
| Brain Code Inc. | 78% |
For institutional investors. Book with your work email.
GLIA Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 13, 2026 | ||||
| Grant | Sep 10, 2021 | ||||
| Accelerator | Jun 12, 2019 |
For institutional investors. Book with your work email.
GLIA Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Australian Government, Department of Defence | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 56% MoM.
- Jun 18, 2026
Monthly visitors increased 42% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
GLIA Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GLIA Diagnostics's valuation, stock price, and market status.
Is GLIA Diagnostics a public or private company?
GLIA Diagnostics is a private company.
What is the current stock price of GLIA Diagnostics?
GLIA Diagnostics is a private company, so its shares have no public market price. Caplight tracks GLIA Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GLIA Diagnostics worth (valuation)?
Valuation information for GLIA Diagnostics is not publicly available.
Can I buy GLIA Diagnostics stock?
GLIA Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GLIA Diagnostics's last funding round?
GLIA Diagnostics's most recent funding round was Seed on July 13, 2026.
Who are the main investors in GLIA Diagnostics?
Key investors in GLIA Diagnostics include Australian Government, Department of Defence.
Will GLIA Diagnostics IPO soon?
No public IPO plans have been announced for GLIA Diagnostics.
How can I track GLIA Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in GLIA Diagnostics's shares on secondary markets.